Annual Drug Patent Expirations for MICARDIS
Micardis is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from one supplier. There is one patent protecting this drug and three Paragraph IV challenges.
This drug has thirty-seven patent family members in eighteen countries.
The generic ingredient in MICARDIS is hydrochlorothiazide; telmisartan. One supplier is listed for this compound. Additional details are available on the hydrochlorothiazide; telmisartan profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
